Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial Intelligence In Pharmaceutical And Health Sciences: Applications, Challenges, And Governance
0
Zitationen
6
Autoren
2026
Jahr
Abstract
Artificial intelligence (ai) transforms pharmaceutical research, from early-stage drug discovery to clinical trial optimization. Deep learning models enable identification of novel molecular targets, predictive toxicity modeling, and precision patient stratification. Despite these advances, ai introduces ethical, regulatory, and methodological challenges including algorithmic bias, reproducibility issues, and model opacity. This review critically examines the applications of ai in pharmaceutical sciences, highlights key case studies, and proposes actionable governance frameworks to ensure safe, transparent, and equitable adoption. Mock data illustrations and tables are included to demonstrate ai-driven predictions and decision-making processes.
Ähnliche Arbeiten
A short history of<i>SHELX</i>
2007 · 87.232 Zit.
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
2009 · 36.409 Zit.
[20] Processing of X-ray diffraction data collected in oscillation mode
1997 · 33.573 Zit.
A new and rapid colorimetric determination of acetylcholinesterase activity
1961 · 26.820 Zit.
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
2009 · 24.581 Zit.